Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Archives of Biochemistry and Biophysics|May 15, 1984
A light-scattering study of bovine factor VIIID G Gabriel, J A Kirkland, H A Cooper, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Platelet-aggregating factor and the aggregation of fixed washed plateletsH A Cooper, K W Wilkins, P R Johnson, et al.
The American Journal of Cardiology|September 25, 1999
White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD])H A Cooper, D V Exner, M A Waclawiw, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1981
The multimeric distribution of factor VIII-related antigen studied by an improved crossed-immunoelectrophoresis techniqueM A Lamb, H M Reisner, H A Cooper, et al.
Cancer|May 1, 1988
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
The Journal of Urology|May 1, 1992
Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladderJ E Oesterling, J P Keating, A J Leroy, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Proteolysis of human fixed, washed platelets by gram-negative bacterial metalloproteases: effect on von Willebrand factor-human platelet interactionsH A Cooper, W P Bennett, A Kreger, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1981
The effect of extracellular proteases from gran-negative bacteria on the interaction of von Willebrand factor with human plateletsH A Cooper, W P Bennett, A Kreger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresH A Cooper, C P Jones, E Campion, et al.
The New England Journal of Medicine|April 9, 1981
A naturally occurring antibody that inhibits fibrin polymerizationW K Hoots, N A Carrell, R H Wagner, et al.
Pageof 8